Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | ||
---|---|---|---|---|---|
Total Revenue | |||||
Cost of Revenue | |||||
Gross Profit | |||||
Gross Profit Margin (%) | |||||
R&D Expense | |||||
SG&A Expense | |||||
Total Operating Expenses | |||||
Operating Income or Loss | |||||
Operating Margin (%) | |||||
Interest Expense | |||||
Total Other Income/Expenses | |||||
Income Before Tax | |||||
Income Tax Expense | |||||
Income from Continuing Ops. | |||||
Net Income | |||||
Net Profit Margin (%) | |||||
Net Income Available to Common Shareholders | |||||
Basic EPS | |||||
Diluted EPS | |||||
Basic Average Shares | |||||
Diluted Average Shares |
Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | Dec 2020 | Sep 2020 | Jun 2020 | Mar 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | |||||||||||||||||||
Cost of Revenue | |||||||||||||||||||
Gross Profit | |||||||||||||||||||
Gross Profit Margin (%) | |||||||||||||||||||
R&D Expense | |||||||||||||||||||
SG&A Expense | |||||||||||||||||||
Total Operating Expenses | |||||||||||||||||||
Operating Income or Loss | |||||||||||||||||||
Operating Margin (%) | |||||||||||||||||||
Interest Expense | |||||||||||||||||||
Total Other Income/Expenses | |||||||||||||||||||
Income Before Tax | |||||||||||||||||||
Income Tax Expense | |||||||||||||||||||
Income from Continuing Ops. | |||||||||||||||||||
Net Income | |||||||||||||||||||
Net Profit Margin (%) | |||||||||||||||||||
Net Income Available to Common Shareholders | |||||||||||||||||||
Basic EPS | |||||||||||||||||||
Diluted EPS | |||||||||||||||||||
Basic Average Shares | |||||||||||||||||||
Diluted Average Shares |
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | ||
---|---|---|---|---|---|
Current Assets | |||||
Cash & Cash Equivalents | |||||
Marketable Securities | |||||
Receivables | |||||
Inventories | |||||
Other Current Assets | |||||
Total Current Assets | |||||
Non-Current Assets | |||||
Marketable Securities | |||||
PPE Net | |||||
Intangibles inc. Goodwill | |||||
Other Non-Current Assets | |||||
Total Non-Current Assets | |||||
Total Assets | |||||
Current Liabilities | |||||
Accounts Payable | |||||
Deferred Revenues | |||||
Debt, Current | |||||
Accrued Liabilities | |||||
Other Current Liabilities | |||||
Total Current Liabilities | |||||
Non-Current Liabilities | |||||
Deferred Revenues | |||||
Debt, Non-Current | |||||
Other Non-Current Liabilities | |||||
Total Non-Current Liabilities | |||||
Total Liabilities | |||||
Shareholders' Equity | |||||
Common Stock | |||||
Additional Paid-In Capital | |||||
Retained Earnings | |||||
Other Shareholders' Equity | |||||
Total Shareholders' Equity | |||||
Total Liabilities & Shareholders' Equity |
Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | Dec 2020 | Sep 2020 | Jun 2020 | Mar 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Current Assets | |||||||||||||||||||
Cash & Cash Equivalents | |||||||||||||||||||
Marketable Securities | |||||||||||||||||||
Receivables | |||||||||||||||||||
Inventories | |||||||||||||||||||
Other Current Assets | |||||||||||||||||||
Total Current Assets | |||||||||||||||||||
Non-Current Assets | |||||||||||||||||||
Marketable Securities | |||||||||||||||||||
PPE Net | |||||||||||||||||||
Intangibles inc. Goodwill | |||||||||||||||||||
Other Non-Current Assets | |||||||||||||||||||
Total Non-Current Assets | |||||||||||||||||||
Total Assets | |||||||||||||||||||
Current Liabilities | |||||||||||||||||||
Accounts Payable | |||||||||||||||||||
Deferred Revenues | |||||||||||||||||||
Debt, Current | |||||||||||||||||||
Accrued Liabilities | |||||||||||||||||||
Other Current Liabilities | |||||||||||||||||||
Total Current Liabilities | |||||||||||||||||||
Non-Current Liabilities | |||||||||||||||||||
Deferred Revenues | |||||||||||||||||||
Debt, Non-Current | |||||||||||||||||||
Other Non-Current Liabilities | |||||||||||||||||||
Total Non-Current Liabilities | |||||||||||||||||||
Total Liabilities | |||||||||||||||||||
Shareholders' Equity | |||||||||||||||||||
Common Stock | |||||||||||||||||||
Additional Paid-In Capital | |||||||||||||||||||
Retained Earnings | |||||||||||||||||||
Other Shareholders' Equity | |||||||||||||||||||
Total Shareholders' Equity | |||||||||||||||||||
Total Liabilities & Shareholders' Equity |
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | ||
---|---|---|---|---|---|
Cash Flows from Operating Activities | |||||
Net Income | |||||
Depreciation & Amortization | |||||
Deferred Income Taxes | |||||
Stock Based Compensation | |||||
Accounts Receivable | |||||
Inventory | |||||
Accounts Payable | |||||
Deferred Revenue | |||||
Other Non-Cash | |||||
Operating Cash Flow | |||||
Cash Flows from Investing Activities | |||||
PPE Investments | |||||
Net Acquisitions | |||||
Purchase of Investments | |||||
Sale of Investments | |||||
Other Investing Activity | |||||
Investing Cash Flow | |||||
Cash Flows from Financing Activities | |||||
Debt Issued | |||||
Proceeds from Debt Repayment | |||||
Debt Repayment | |||||
Proceeds from Sale of Equity | |||||
Equity Repurchased | |||||
Dividend Paid | |||||
Other Financing Activity | |||||
Financing Cash Flow | |||||
Cash Position | |||||
Beginning Cash Position | |||||
End Cash Position | |||||
Change in Cash | |||||
Free Cash Flow | |||||
Operating Cash Flow | |||||
Capital Expenditure | |||||
Free Cash Flow |
Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | Dec 2020 | Sep 2020 | Jun 2020 | Mar 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flows from Operating Activities | |||||||||||||||||||
Net Income | |||||||||||||||||||
Depreciation & Amortization | |||||||||||||||||||
Deferred Income Taxes | |||||||||||||||||||
Stock Based Compensation | |||||||||||||||||||
Accounts Receivable | |||||||||||||||||||
Inventory | |||||||||||||||||||
Accounts Payable | |||||||||||||||||||
Deferred Revenue | |||||||||||||||||||
Other Non-Cash | |||||||||||||||||||
Operating Cash Flow | |||||||||||||||||||
Cash Flows from Investing Activities | |||||||||||||||||||
PPE Investments | |||||||||||||||||||
Net Acquisitions | |||||||||||||||||||
Purchase of Investments | |||||||||||||||||||
Sale of Investments | |||||||||||||||||||
Other Investing Activity | |||||||||||||||||||
Investing Cash Flow | |||||||||||||||||||
Cash Flows from Financing Activities | |||||||||||||||||||
Debt Issued | |||||||||||||||||||
Proceeds from Debt Repayment | |||||||||||||||||||
Debt Repayment | |||||||||||||||||||
Proceeds from Sale of Equity | |||||||||||||||||||
Equity Repurchased | |||||||||||||||||||
Dividend Paid | |||||||||||||||||||
Other Financing Activity | |||||||||||||||||||
Financing Cash Flow | |||||||||||||||||||
Cash Position | |||||||||||||||||||
Beginning Cash Position | |||||||||||||||||||
End Cash Position | |||||||||||||||||||
Change in Cash | |||||||||||||||||||
Free Cash Flow | |||||||||||||||||||
Operating Cash Flow | |||||||||||||||||||
Capital Expenditure | |||||||||||||||||||
Free Cash Flow |